Federal Register Notice for Hepatitis B Screening and Testing [ARCHIVED]

On April 4, 2022, the Centers for Disease Control and Prevention (CDC) published a Federal Register Notice (FRN) #CDC-2022-07050 to obtain comment on proposed hepatitis B screening and testing recommendations. The recommendations supplement CDC’s 2008 screening recommendations by including hepatitis B screening at least once in a lifetime for adults aged 18 years and older, using a three-test panel. Screening with three tests can help identify persons who have a current HBV infection, have resolved infection and who may be susceptible to reactivation, are susceptible and need vaccination, or are vaccinated.

The Federal Register Notice, docket number CDC-2022-0044, will be open for public comment for 60 days and closes on June 3, 2022.

Learn More about this Federal Register Notice

CDC hosted a webinar on April 20, 2022, at 2pm ET presenting an overview of the proposed recommendations.

Click here to view the webinar slides [PDF – 728 KB].


Send questions about the FRN or how to post a comment to: DVHpolicy@cdc.gov